Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NUSINERSEN vs RISDIPLAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NUSINERSEN vs RISDIPLAM: Safety Overview

Metric NUSINERSEN RISDIPLAM
Total FAERS Reports 7,043 3,619
Deaths Reported 747 336
Death Rate 10.6% 9.3%
Hospitalizations 2,188 719
Average Patient Age 17.1 yrs 21.8 yrs
% Female Patients 50.1% 55.2%
FDA Approval Date Dec 23, 2016 Aug 7, 2020
Manufacturer Biogen Inc. Genentech, Inc.
Route INTRATHECAL ORAL
Marketing Status Prescription Prescription